977 related articles for article (PubMed ID: 11380964)
1. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
[TBL] [Abstract][Full Text] [Related]
2. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
Hendricks SK; Sorensen TK; Baker ER
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21.
Baschat AA; Wagner T; Malisius R; Gembruch U
Prenat Diagn; 1998 Jul; 18(7):731-6. PubMed ID: 9706656
[TBL] [Abstract][Full Text] [Related]
4. Fetal hepatosplenomegaly associated with transient myeloproliferative disorder in trisomy 21.
Macones GA; Johnson A; Tilley D; Wade R; Wapner R
Fetal Diagn Ther; 1995; 10(2):131-3. PubMed ID: 7794514
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine diagnosis and management of transient myeloproliferative disorder.
Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
[TBL] [Abstract][Full Text] [Related]
6. The association between congenital heart disease and Down syndrome in prenatal life.
Paladini D; Tartaglione A; Agangi A; Teodoro A; Forleo F; Borghese A; Martinelli P
Ultrasound Obstet Gynecol; 2000 Feb; 15(2):104-8. PubMed ID: 10775990
[TBL] [Abstract][Full Text] [Related]
7. Fetal hepatosplenomegaly: an isolated sonographic sign of trisomy 21 in a case of myeloproliferative disorder.
Hartung J; Chaoui R; Wauer R; Bollmann R
Ultrasound Obstet Gynecol; 1998 Jun; 11(6):453-5. PubMed ID: 9674095
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
9. Middle cerebral artery Doppler velocimetric assessment in two cases of hydrops fetalis without fetal anaemia.
Shah NK; Martin WL; Whittle MJ
Prenat Diagn; 2004 Jan; 24(1):17-8. PubMed ID: 14755403
[TBL] [Abstract][Full Text] [Related]
10. Reference values of fetal ductus venosus, inferior vena cava and hepatic vein blood flow velocities and waveform indices during the second and third trimester of pregnancy.
Axt-Fliedner R; Wiegank U; Fetsch C; Friedrich M; Krapp M; Georg T; Diedrich K
Arch Gynecol Obstet; 2004 Jul; 270(1):46-55. PubMed ID: 15190437
[TBL] [Abstract][Full Text] [Related]
11. Hypoechoic hepatomegaly associated with transient abnormal myelopoiesis provides clues to trisomy 21 in the third-trimester fetus.
Hamada H; Yamada N; Watanabe H; Okuno S; Fujiki Y; Kubo T
Ultrasound Obstet Gynecol; 2001 May; 17(5):442-4. PubMed ID: 11380972
[TBL] [Abstract][Full Text] [Related]
12. [Ductus venosus agenesis].
Durakovic N; Azancot A; Eurin D; Menez F; Vuillard E; Garel C; Luton D; Delezoide AL
Arch Mal Coeur Vaiss; 2005 May; 98(5):542-8. PubMed ID: 15966606
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Lambert-Messerlian GM; Saller DN; Tumber MB; French CA; Peterson CJ; Canick JA
Prenat Diagn; 1998 Oct; 18(10):1061-7. PubMed ID: 9826898
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of congenital leukemia in a fetus at 25 weeks' gestation with Down syndrome: case report and review of the literature.
Robertson M; De Jong G; Mansvelt E
Ultrasound Obstet Gynecol; 2003 May; 21(5):486-9. PubMed ID: 12768562
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
16. Invasive testing for the karyotyping of mid-trimester intrauterine fetal death (IUFD): a pilot study.
Howarth ES; Konje JC; Healey KA; Duckett DP; Scudamore IW; Taylor DJ
Prenat Diagn; 2002 Jun; 22(6):453-5. PubMed ID: 12116301
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic evaluation of cystic hygroma associated with hydrops fetalis, oligohydramnios or intrauterine fetal death: the roles of amniocentesis, postmortem chorionic villus sampling and cystic hygroma paracentesis.
Chen CP; Liu FF; Jan SW; Lee CC; Town DD; Lan CC
Acta Obstet Gynecol Scand; 1996 May; 75(5):454-8. PubMed ID: 8677770
[TBL] [Abstract][Full Text] [Related]
18. Management of non-immune hydrops: 8 years' experience.
Anandakumar C; Biswas A; Wong YC; Chia D; Annapoorna V; Arulkumaran S; Ratnam S
Ultrasound Obstet Gynecol; 1996 Sep; 8(3):196-200. PubMed ID: 8915090
[TBL] [Abstract][Full Text] [Related]
19. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
Enders M; Weidner A; Zoellner I; Searle K; Enders G
Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
[TBL] [Abstract][Full Text] [Related]
20. Prenatal eradication of Hb Bart's hydrops fetalis.
Tongsong T; Wanapirak C; Sirivatanapa P; Sa-nguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P; Steger HF; Sekararithi R; Tuggapichitti A
J Reprod Med; 2001 Jan; 46(1):18-22. PubMed ID: 11209626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
